While it can be easy to treat in vitro #ADME & #DrugInteractions evaluation as just a checklist for regulatory submission, rubber stamping a standard set of studies may leave critical compound-specific questions unanswered. Read more: https://t.co/hv86hvjwky
#Preclinical#DMPK
Research moves forward because people choose to participate. Donors play a direct role in enabling studies that deepen scientific understanding & support the development of new diagnostics & treatments.
Learn more:
US → https://t.co/UUtrvVns1l
UK → https://t.co/hqDwf6QOUI
How do processing delays affect #Alzheimers#biomarker reliability?
Hear from Dr. Miller on why time-to-spin protocols matter for consistent results across clinical sites and watch the full webinar for more: https://t.co/V2bzwyw7jS
#AlzheimersDisease#AlzheimersDiagnostics
For complex liver models, there's no one-size-fits-all approach. Choosing the right non-parenchymal cells (NPCs) depends on your research goals. Read our blog to learn how to select the right cells for your model: https://t.co/VxQI53Dx1c
#Inflammation#Fibrosis#Pathology
We’re wrapping up 2026 with some great events on #exosomes & other #biospecimens, #AI & #NAMs, #ADME & #toxicity, and more. Get the full details in our latest Events Newsletter: https://t.co/p8e1S8bsBx
Each #LiquidBiopsy analyte presents unique biological challenges.
In part two of our liquid biopsy blog series, Dr. Courtney Noah explores analyte-specific failure models and considerations for reproducible results.
Read more: https://t.co/R5gq8t9Cn0
In #CellTherapy development, having sufficient starting material is critical. Our Leukomax XL fresh #leukopaks deliver a minimum of 15 billion total nucleated cells with:
• Fresh delivery within 24 hrs near US & UK hubs
• Cryo options shipped globally
https://t.co/SJqjXLZPfO
We've spotted some scary habits creeping into the #CellCulture lab... and they're enough to make any scientist scream!
For #Halloween again this year, we’re shining a blacklight on these spooky slip-ups to help you avoid endangering your research: https://t.co/LQAl7dp5cw
Dr. Mueller’s TPD & Induced Proximity Summit poster “The In Vitro #ADME Playbook for #ProteinDegraders: What's Different?” is now available to download here: https://t.co/V7yq4Y6wma
Watch her presentation here: https://t.co/n1duYt8jAy
#DrugInteractions#DMPK#DrugMetabolism
Our experts put their decades of experience guiding researchers to the right test systems for #ADME studies by outlining the important considerations around drug characteristics & study objectives. Download now: https://t.co/PYAmr4Podx
#DMPK#DrugMetabolism#DrugInteractions
In #multiomics#oncology research, not every analyte can be treated equally. Prioritize your primary endpoint to optimize workflows around what matters most.
Hear more from Dr. Noah in her full webinar: https://t.co/Hsxr0ZLYYp
#OncologyResearch#Biomarkers#BiomarkerDiscovery
In #ImmunologyResearch, shared diagnoses don't always mean comparable biology. Donor characteristics, sample quality, and clinical context all matter when designing studies.
Explore how BioIVT support #immunology research: https://t.co/5hoalxW0sD
If you’re attending the TPD & Induced Proximity Summit this week, make sure to visit Kevin Mertz at the BioIVT table & catch Dr. Tina Mueller’s presentation & poster on #ADME evaluation of #ProteinDegraders: https://t.co/4ibrzP5yOz
#DMPK#DrugMetabolism#DrugInteractions
Join our team at #AAPS#PharmSci360 booth #1107 to discuss all your normal and disease-state #biospecimen or #ADME study questions and needs and don't miss the symposium on #NAMs, moderated by Dr. Kent Grindstaff: https://t.co/scrnFOHM2W
Following our Building the Future of #AlzheimersDisease#Diagnostics webinar, Dr. Cathie Miller explores why matrix and tube selection matter for reliable assay performance. Watch her response and explore the full webinar: https://t.co/wXYDp6NZDo
#Alzheimers#Biomarkers
What does it take to move #NewApproachMethodologies from promising research alternatives to reliable research tools? In our latest blog, we explore important considerations in successful implementation of #NAMs: https://t.co/2Gxvwv7d5O
From compound structures to entirely different modalities, drugs differ drastically from each other. So, why rubber stamp the same #ADME/#DDI studies? Get expert guidance on fit-for-purpose program & #StudyDesign: https://t.co/6nEPz7L30G
#DMPK#DrugInteractions#DrugMetabolism
Testing for potential #DrugInteractions is an important part of assessing the safety of new drug candidates & includes a variety of different studies, such as enzyme induction. Watch an overview of important considerations when evaluating CYP induction: https://t.co/Ksn43vCoEb
Heterogeneity has a big impact on #autoimmune research. From discovery through development, we help researchers obtain the right biology, donor context & sample quality to generate more relevant, reproducible & translationally meaningful insights: https://t.co/9y6SVIruJo